GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Beneish M-Score

Gaush Meditech (HKSE:02407) Beneish M-Score : -2.58 (As of May. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Gaush Meditech's Beneish M-Score or its related term are showing as below:

HKSE:02407' s Beneish M-Score Range Over the Past 10 Years
Min: -3.3   Med: -3.27   Max: -2.58
Current: -2.58

During the past 5 years, the highest Beneish M-Score of Gaush Meditech was -2.58. The lowest was -3.30. And the median was -3.27.


Gaush Meditech Beneish M-Score Historical Data

The historical data trend for Gaush Meditech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Beneish M-Score Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -3.30 -3.27 -2.58

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial -3.30 - -3.27 - -2.58

Competitive Comparison of Gaush Meditech's Beneish M-Score

For the Medical Devices subindustry, Gaush Meditech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaush Meditech's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's Beneish M-Score falls into.



Gaush Meditech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gaush Meditech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8923+0.528 * 1.0141+0.404 * 1.0025+0.892 * 1.0986+0.115 * 0.9084
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0098+4.679 * -0.026555-0.327 * 0.887
=-2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$242.0 Mil.
Revenue was HK$1,538.1 Mil.
Gross Profit was HK$756.5 Mil.
Total Current Assets was HK$1,521.3 Mil.
Total Assets was HK$3,110.4 Mil.
Property, Plant and Equipment(Net PPE) was HK$137.9 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$83.1 Mil.
Selling, General, & Admin. Expense(SGA) was HK$413.7 Mil.
Total Current Liabilities was HK$975.3 Mil.
Long-Term Debt & Capital Lease Obligation was HK$138.7 Mil.
Net Income was HK$189.8 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$272.4 Mil.
Total Receivables was HK$246.9 Mil.
Revenue was HK$1,400.1 Mil.
Gross Profit was HK$698.3 Mil.
Total Current Assets was HK$1,481.1 Mil.
Total Assets was HK$3,035.3 Mil.
Property, Plant and Equipment(Net PPE) was HK$141.5 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$73.4 Mil.
Selling, General, & Admin. Expense(SGA) was HK$372.9 Mil.
Total Current Liabilities was HK$550.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$675.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(242.028 / 1538.113) / (246.913 / 1400.12)
=0.157354 / 0.176351
=0.8923

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(698.324 / 1400.12) / (756.457 / 1538.113)
=0.49876 / 0.491808
=1.0141

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1521.267 + 137.898) / 3110.398) / (1 - (1481.137 + 141.548) / 3035.331)
=0.466575 / 0.465401
=1.0025

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1538.113 / 1400.12
=1.0986

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(73.422 / (73.422 + 141.548)) / (83.091 / (83.091 + 137.898))
=0.341545 / 0.375996
=0.9084

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(413.68 / 1538.113) / (372.91 / 1400.12)
=0.268953 / 0.266341
=1.0098

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((138.662 + 975.287) / 3110.398) / ((675.486 + 550.119) / 3035.331)
=0.358137 / 0.40378
=0.887

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(189.796 - 0 - 272.393) / 3110.398
=-0.026555

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gaush Meditech has a M-score of -2.58 suggests that the company is unlikely to be a manipulator.


Gaush Meditech Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gaush Meditech (HKSE:02407) Business Description

Traded in Other Exchanges
N/A
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.

Gaush Meditech (HKSE:02407) Headlines

No Headlines